Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination.

R. Hoekstra, FYFL de Vos, F.A. Eskens, E.G.E. de Vries, D.R.A. Uges, R.T. Knight, R.A. Carr, R.A. Humerickhouse, J Verweij, J.A. Gietema

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)467-472
JournalEuropean Journal of Cancer
Publication statusPublished - Mar 2006

Cite this